Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward William Gallagher, University College Dublin, speaking at Diagnostics & Biomarkers 2015.
Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer Sarah Hayes, University of Sydney, speaking at Diagnostics & Biomarkers 2015.
Microwave-to-Terahertz Sensing in Microfluidic Systems Norbert Klein, Imperial College London, speaking at Lab-on-a-Chip & Microfluidics 2015
Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit Kevin Cox, Imanova Limited, speaking at Diagnostics & Biomarkers.
Development of a Point-of-Care Diagnostic for Influenza Detection with Antiviral Treatment Effectiveness Indication Richard Murdock, USAF, speaking at Point of Care Diagnostics 2015
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM) Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends Julia Trosman, Center for Business Models in Healthcare, speaking at Diagnostics & Biomarkers 2015.
Interfering Peptides Targeting Protein-Protein Interactions Katja Arndt, University of Potsdam, speaking at Discovery Chemistry Congress 2015.
Highly-integrated Lab-on-a-chip System for Multiparameter Analysis at the Point-of-care Harald Peter, Fraunhofer Institute for Cell Therapy and Immunology IZI-BB
Imaging Biomarkers - Future or Reality Edwin van Beek, University of Edinburgh, speaking at Diagnostics & Biomarkers 2015.